News
Eli Lilly (NYSE:LLY), a major pharmaceutical company listed on the S&P 500 and NYSE Composite, continues to attract attention ...
Zacks Investment Research on MSN20h
What is the Intent Behind Eli Lilly's Recent M&A Deals Spree?Eli Lilly LLY signed a definitive agreement to acquire Verve Therapeutics VERV for a total deal value of nearly $1.3 billion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback